Recently, IKKε has been associated with obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), and IKKε inhibition suppresses inflammation and increases energy expenditure and thermogenesis. The gene discussed is IKBKE; the disease is metabolic dysfunction-associated steatotic liver disease.